167 related articles for article (PubMed ID: 33951538)
1. The long noncoding RNA AATBC promotes breast cancer migration and invasion by interacting with YBX1 and activating the YAP1/Hippo signaling pathway.
Wang M; Dai M; Wang D; Tang T; Xiong F; Xiang B; Zhou M; Li X; Li Y; Xiong W; Li G; Zeng Z; Guo C
Cancer Lett; 2021 Aug; 512():60-72. PubMed ID: 33951538
[TBL] [Abstract][Full Text] [Related]
2. A novel long non-coding RNA AC073352.1 promotes metastasis and angiogenesis via interacting with YBX1 in breast cancer.
Kong X; Li J; Li Y; Duan W; Qi Q; Wang T; Yang Q; Du L; Mao H; Wang C
Cell Death Dis; 2021 Jul; 12(7):670. PubMed ID: 34218256
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
4. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.
Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC
Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116
[TBL] [Abstract][Full Text] [Related]
5. LncRNA AATBC regulates Pinin to promote metastasis in nasopharyngeal carcinoma.
Tang T; Yang L; Cao Y; Wang M; Zhang S; Gong Z; Xiong F; He Y; Zhou Y; Liao Q; Xiang B; Zhou M; Guo C; Li X; Li Y; Xiong W; Li G; Zeng Z
Mol Oncol; 2020 Sep; 14(9):2251-2270. PubMed ID: 32364663
[TBL] [Abstract][Full Text] [Related]
6. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
7. H3K27 acetylation activated long noncoding RNA RP11-162G10.5 promotes breast cancer progression via the YBX1/GLO1 axis.
Xie N; Zhang R; Bi Z; Ren W; You K; Hu H; Xu Y; Yao H
Cell Oncol (Dordr); 2023 Apr; 46(2):375-390. PubMed ID: 36576700
[TBL] [Abstract][Full Text] [Related]
8. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway.
Qiao K; Ning S; Wan L; Wu H; Wang Q; Zhang X; Xu S; Pang D
J Exp Clin Cancer Res; 2019 Oct; 38(1):418. PubMed ID: 31623640
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA PRKCQ-AS1 promotes CRC cell proliferation and migration via modulating miR-1287-5p/YBX1 axis.
Cui G; Zhao H; Li L
J Cell Biochem; 2020 Oct; 121(10):4166-4175. PubMed ID: 32619070
[TBL] [Abstract][Full Text] [Related]
10. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of a novel lincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancer.
Zhao F; Lin T; He W; Han J; Zhu D; Hu K; Li W; Zheng Z; Huang J; Xie W
Oncotarget; 2015 Jan; 6(2):1064-78. PubMed ID: 25473900
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA SNHG6 promotes carcinogenesis by enhancing YBX1-mediated translation of HIF1α in clear cell renal cell carcinoma.
Zhao P; Deng Y; Wu Y; Guo Q; Zhou L; Yang X; Wang C
FASEB J; 2021 Feb; 35(2):e21160. PubMed ID: 33150667
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma.
Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Lu J; Chen GQ; Zheng YL
Cell Death Dis; 2018 Sep; 9(10):947. PubMed ID: 30237435
[TBL] [Abstract][Full Text] [Related]
14. Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling.
Zhou Y; Shan T; Ding W; Hua Z; Shen Y; Lu Z; Chen B; Dai T
J Cell Physiol; 2018 Aug; 233(8):5805-5814. PubMed ID: 29215734
[TBL] [Abstract][Full Text] [Related]
15. lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer.
Liu Y; Zhao J; Zhang W; Gan J; Hu C; Huang G; Zhang Y
Sci Rep; 2015 May; 5():10159. PubMed ID: 25959498
[TBL] [Abstract][Full Text] [Related]
16. LncRNA wires up Hippo and Hedgehog signaling to reprogramme glucose metabolism.
Zheng X; Han H; Liu GP; Ma YX; Pan RL; Sang LJ; Li RH; Yang LJ; Marks JR; Wang W; Lin A
EMBO J; 2017 Nov; 36(22):3325-3335. PubMed ID: 28963395
[TBL] [Abstract][Full Text] [Related]
17. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway.
Zhang C; Bao C; Zhang X; Lin X; Pan D; Chen Y
Cancer Biol Ther; 2019; 20(9):1213-1222. PubMed ID: 30983488
[TBL] [Abstract][Full Text] [Related]
19. Effects of the hippo signaling pathway in human gastric cancer.
Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
[TBL] [Abstract][Full Text] [Related]
20. lncRNA FGD5‑AS1 promotes breast cancer progression by regulating the hsa‑miR‑195‑5p/NUAK2 axis.
Fang K; Xu ZJ; Jiang SX; Tang DS; Yan CS; Deng YY; Zhao FY
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]